Fenofibrate: a new treatment for hyperuricaemia and gout?
Open Access
- 1 October 2001
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 60 (10) , 984-986
- https://doi.org/10.1136/ard.60.10.984a
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Serum Uric Acid and Cardiovascular MortalityJAMA, 2000
- Serum Uric Acid and Risk of Coronary Heart DiseaseAnnals of Epidemiology, 2000
- Atherogenic lipoprotein phenotype in Type 2 diabetes: reversal with micronised fenofibrateDiabetes/Metabolism Research and Reviews, 1999
- Hyperlipidaemia in hyperuricaemia and goutAnnals of the Rheumatic Diseases, 1998
- Hypertriglyceridemia and hyperuricemia: Effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trialMetabolism, 1988
- Hyperuricemia and hypertriglyceridemia: Metabolic basis for the associationMetabolism, 1985
- Uricosuric Effect of Fenofibrate in Healthy VolunteersThe Journal of Clinical Pharmacology, 1980
- Blood Lipid and Uric Acid InterrelationshipsPublished by American Medical Association (AMA) ,1964
- Hypertriglyceridemia in GoutCirculation, 1964